InvestorsHub Logo
Followers 1184
Posts 134793
Boards Moderated 3
Alias Born 08/27/2003

Re: None

Thursday, 07/31/2014 12:51:46 PM

Thursday, July 31, 2014 12:51:46 PM

Post# of 8592
REPR = possible HALO supplier....

There is the potential for new drugs to enter the market, containing products such as Hyaluronidase, which can facilitate absorption of IgG, making multiple site infusions unnecessary and changing the market conditions for devices such as the FREEDOM60®. We believe the FREEDOM60® is ideal for all these new drug combinations, but there can be no assurance that these newer drugs will have the same needs and requirements as the current drugs being used.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10095834

July 31 FDA news -- HyQvia for primary immune deficiency disorders
SubQ IgG 10% human w/ recombinant human hyaluronidase
https://twitter.com/FDAadcomm/status/494599539907497985/photo/1

The SwingTrade Portfolio is up 28.3% YTD through 5/30/2014, 83.5% in 2013, and 475.5% since inception.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=102716798

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News